A Harvard scientist thinks he’s reached a new milestone: a genetic test that helps identify people who are at high risk of having a heart attack. Can he convince doctors to use it?
PROGRAMS AND INCENTIVES TO SPUR BUSINESS GROWTH
We help you navigate available programs, grants and incentives to identify immediate opportunities and plan for long-term success. Check out the very successful MOVE program, small business programs and incentives geared to specific industries.
GlycoMimetics, Inc. (NASDAQ: GLYC), a biopharmaceutical company focused on discovering and developing novel small-molecule drug candidates to treat rare diseases, announced today that the Japan Patent Office (JPO) has issued Patent No. 6366150, for uproleselan (GMI-1271). The newly issued patent covers uproleselan’s composition of matter as well as pharmaceutical formulations, and expires in December 2032.
Popper and Co., a strategy consulting and transaction advisory firm serving the needs of the medical technology and life sciences industries, announced today that Co-Founder and President Caroline Popper, M.D., will speak at the 10th Annual Next Generation Dx Summit on August 22 at 5 pm ET at the Grand Hyatt Washington in Washington, DC.
Calling all pediatric cardiovascular devices $100K competition now accepting proposals
We are now accepting proposals for our annual pediatric medical device pitch competition! New this year, the competition is focused on pediatric cardiovascular devices – a significant unmet need for children. The competition will be held on Sunday, Sept. 23, 2018 in Philadelphia, Penn. at our 6th Annual Pediatric Device Innovation Symposium. The deadline to apply is Monday, Sept. 10. For additional competition details and to apply, click here.
The Emmes Corporation today announced that it was selected as one of the best places to work in the greater Washington area. The Washington Post’s 2017 Top Workplaces list ranked private, public, nonprofit and government agencies based on the highest engagement ratings from their employees. The Washington Post used Workplace Dynamics to conduct the survey, with 3,000 area companies invited to participate and 150 organizations selected as Top Workplaces. Emmes was ranked 15th out of 25 in the large company category and was one of only two biotechnology organizations to make the list.
RegenxBio Inc. (NASDAQ:RGNX) raised $175.5 million through the sale of 2.7 million shares at $65 in a follow-on underwritten by Morgan Stanley, BofA Merrill Lynch, Barclays and Raymond James.
Venture investor Krishna Yeshwant uses a healthy amount of skepticism when vetting potential companies to invest in. His favorite time to invest is when one of his partners at the fund is excited about a particular company, even if nobody else is.
To better understand one of the most heated U.S. policy debates, we created a tournament to judge which of these nations has the best health system: Canada, Britain, Singapore, Germany, Switzerland, France, Australia and the U.S.
In the first such clinical trial in the United States, physician-scientists with the University of Maryland School of Medicine (UMSOM) are investigating the use of MRI-guided focused ultrasound to open the blood-brain barrier. The trial will be conducted with patients undergoing brain cancer surgery at the University of Maryland Medical Center (UMMC).